ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Causal links among gut microbiota, immune-inflammatory and compensatory immune-regulatory systems, and schizophrenia.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fecal microbiota transplantation: from empirical remedy to precision medicine.Frontiers in microbiomes · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Schizophrenia (SCZ) has been increasingly linked to disruptions in gut microbiota (GM) and immune system dysregulation, including the immune-inflammatory response system (IRS) and compensatory immune-regulatory system (CIRS). To investigate their causal roles and potential confounding effects, we applied genetically informed Mendelian randomization (MR) using genome-wide association study (GWAS) data from a large SCZ meta-analysis (52,017 cases and 75,889 controls), 72 GM genera, and 22 traits of IRS, CIRS, and immune cell indices of European ancestry cohorts. We followed the STROBE-MR guidelines for the MR approach. We found complex causality involving both protective and risk effects. Our analysis revealed protective causal effects of GM genera Barnesiella, Desulfovibrio, Gordonibacter, and Romboutsia (OR = 0.85-0.93, p = 0.005-0.00018), and a risk effect from Clostridium innocuum (OR = 1.09, p = 0.007). Notably, Barnesiella and Gordonibacter represent novel findings. Among immune traits, tumor necrosis factor receptor 1 (sTNF-R1) showed a protective effect (OR = 0.83, p = 0.047), whereas regulatory T cell (Treg) counts increased the risk of SCZ (OR = 1.05, p = 0.006). Multivariate MR confirmed the independent effects of Desulfovibrio, Gordonibacter, and sTNF-R1 after adjusting for other traits. The identified bacterial genera and immune measures exhibit biological relevance to the pathogenesis of SCZ. These findings suggest that specific GM and immune traits contribute independently to SCZ pathogenesis. Particularly, cumulating evidence supporting Tregs as a therapeutic target for psychosis underscores the significance of our results. Further research on their function is needed to validate the causal role of the identified gut microbes and immune mechanisms in SCZ.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.